Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19

Eileen McGowan(University of Technology Sydney), Yiguang Lin(Sun Yat-sen University)

International Journal of Molecular Sciences

September 29, 2020

10.3390/ijms21197189

Cited by 51

Related Papers

Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

|Nature|2006|2.1k

Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function

|Science|2005|2k

Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP

|Science|2001|1.6k

Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice

|Journal of Neuroscience|2010|574

Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice

|Neuron|2005|557